The investment at Naivasha SEZ is expected to contribute to technology transfer, skills development and job creation while strengthening Kenya’s pharmaceutical manufacturing capacity.
The summit will examine reforms covering healthcare financing, primary and specialised care, health commodities, digital health, the health workforce, and maternal and newborn health.
The licensing agreement will allow UCL to manufacture and supply generic alimatravir in African countries and other markets covered by the agreement, subject to successful clinical development and regulatory approval.
The centres will provide comprehensive services, including antenatal and postnatal care, labour and recovery services, obstetric care, Caesarean sections, theatres, maternal and neonatal intensive care, neonatal intensive care units and post-Caesarean wards.
The appointments will see Dr. Patel take over the chairmanship from Dr. Manoj Shah, who has led the Board through a period of significant development for the Nairobi-based hospital.
Keyhole surgery, also known as minimally invasive surgery, involves making small incisions through which surgeons insert specialized instruments and a camera to perform an operation.
The hospital successfully conducted two total hip replacement procedures in a carefully planned three-hour operation led by a multidisciplinary team of specialists.
The Centre operates through the SHA 922 Lifeline and will coordinate ambulance deployment, emergency communications, patient referrals and links between emergency responders and health facilities.
The partnership will unlock KSh10.4 billion (US$80 million) over the next five years to accelerate implementation of Kenya’s Every Woman Every Newborn Everywhere (EWENE) Acceleration Plan and support the country’s 90-90-80-80 maternal and newborn health targets.
The expanded role is expected to strengthen referral services across Western Kenya and the wider East African region while reducing pressure on national referral hospitals.